Monthly Archives: September 2016

Emily’s Journey to Perfect Hair with Wen by Chaz by Her Side

Ladies, there is always something to dislike about your hair. Whether it is too thin, dry, or flat, there is a factor that could be improved. Emily McClure knows this reality all too well and determined that she would give one of those luxury products she has seen on television one too many times a try. With her self-proclaimed fine hair in tow, she headed to the store to purchase a Wen by Chaz cleansing conditioner.
For those who do not know, WEN hair products were crafted by celebrity stylist, Chaz Dean. The philanthropic stylist has studied and worked on hair for decades, meaning that he undoubtedly understands what every strand needs and how they can possibly get those vitamins and nutrients. Equipped with his knowledge and willingness to help everyone from stars to average people trucking through life, Chaz developed this Sephora endorsed products and has single handedly transformed the way hair looks and feels across the country.

With this background knowledge and a little bit of skepticism, Emily began her experiment, a test set to last for one week. Upon using it at first, she did not necessarily like the amount of product she was recommended to use, but when that formula touched her hair, she abolished those complaints with surprise and happiness. With hair that was instantaneously soft, Emily went to sleep that night eager to see her hair in the morning.

The following day was met with complaints of greasy hair, but Emily determined that she did not wash the product out thoroughly enough. Alas, she continued her experiment and found the same, soft results. The days continued and few complaints were offered by the transforming beauty. When she met with her friends for drinks when the test was coming to a close, they asked her why her hair looked so fabulous. These questions and compliments only supported Emily’s use of Wen by Chaz products and secured her desire to use them again. Check out the product’s Wikipedia page for more info.

http://www.qvc.com/beauty/wen/_/N-rhtyZ1z141dz/c.html

http://www.ebay.com/bhp/wen-hair-care

Hippeas: Snacking Smart Made Simple

livio hippeas

Would you believe these puffs are HEALTHY?

 

A Guy Named Livio Bisterzo Wants You To Snack Healthy While Helping Planet And People, Spread The Word

I am always frustrated when I am hungry but don’t have time for a proper meal. You are bound to buy something you can get your hands on quickly and food products that you can get your hands on quickly are never healthy. Consider the candy bar, a bag of chips or worse, like a fast food burger.

I also don’t like voting. By voting, I mean with my money as a consumer. Every time I purchase unhealthy food, I support that product by voting for it with my money. That product gets to sustain its reign of unhealthy terror because of the money I put towards it. But all that has come to and end because of one simple, delicious little snack bag that I found in Starbucks the other day. It’s called Hippeas.

The name is a play on the old hippy movement of the 60’s. You can even see it in the brightly colored bag. But the idea is that it is a food that a hippy would buy because of its ingredients and how the company treats the planet. Meanwhile, the packaging is pretty hip. It’s covered in funny jokes and information about the company, making you well informed about what goes into the product.

It’s made out of chickpeas, but they look and kind of feel like cheese puffs or a piece of snack mix. They feel hearty in your mouth and the chickpea delivers four grams of protein per serving backed up by three grams of fiber. That means you get sustained energy like you’re eating actual food.

One the hippie side of things, the chickpea plant literally feeds the planet with nitrogen. The soil gets the nutrient as the plant grows. And Hippeas buys into this program called Farm Africa, which helps farmers learn sustainable farming techniques and business practices to help them make money. Everyone seems to be winning, including me.

I dug around a little and found this is the workings of an Italian entrepreneur named Livio Bisterzo. The guy has tons of history in the sustainable food business even though he is young, taking a juice and tea company global not too long ago. Before that, he brought a men’s grooming product named Kyoku to 28 countries.

But the cool thing about Livio Bisterzo is that he’s trying to change the world with his Hippeas. And if the word gets out, he’ll definitely do it. Please share.

Seattle Genetics Developing Therapies for Cancer Treatment

Dr. Siegall co-founded Seattle Genetics, Inc. in 1997. He has been its president since June 2000 and CEO since November 2002. Additionally, Dr. Siegall is Chairman of the Board. Seattle Genetics has brought numerous developments to the company since he was elected president and CEO. Under his direction, the company has created a broad pipeline of antibody-drug conjugate (ADCs) for the treatment of cancer. Among the ADCs s the ADCETRIS that was approved by the U.S. FDA in 2011. Clay Siegall has over 15 years of experience in cancer research and therapeutic drug development.

He has worked at major biotechnology companies including Bristol-Myers Squibb Pharmaceutical Research Institute, Alder Biopharmaceuticals, Ultragenyx Pharmaceutical Inc, Washington Biotechnology and Biomedical Association among others. Clay Siegall also joined Mirna Therapeutics, a biotechnology-based company in January 2013. He was appointed to join the Board of Directors as an outside director.

 

Seattle Genetics is a biotechnology corporation that centers on the development and commercialization of therapies for the treatment of cancer and autoimmune diseases. Incorporated on July 15, 1997, the company’s product ADCETRIS (brentuximab vedotin), is an antibody-drug conjugate (ADC) which comprises of an anti-CD30 monoclonal antibody held by a protease-cleavable linker to monomethyl auristatin E (MMAE).

Apart from ADCETRIS (brentuximab vedotin), the Company’s pipeline in various stages of clinical trials consists of SGN-CD19A, SGN-CD33A, SGN-CD70A, ASG-22ME, SGN-LIV1A, and ASG-15ME, and SEA-CD40, an ADC based on its sugar-engineered antibody SEA technology.

ADCETRIS

This product uses a linker system formulated to stabilize in the bloodstream to release cell-killing agent, MMAE directly into CD30-positive cells. Regulatory authorities in over 60 nations have approved marketing authorization of brentuximab vedotin in relapsed systemic anaplastic large cell lymphoma (sALCL) and relapsed Hodgkin lymphoma.

The product has also been approved for intravenous injection for three indications including standard approval for the treatment of relapsed classical Hodgkin lymphoma; standard approval for the treatment of patients suffering from classical HL when auto-hematopoietic stem cell transplantation or multi-agent chemotherapy regimens fails and for the treatment of patients suffering from sALCL when one prior multi-agent chemotherapy regimen fails.

Development Collaboration

Seattle Genetics in collaboration with Takeda Pharmaceutical Company are responsible for the development of ADCETRIS (brentuximab vedotin). The two biotechnology companies finance joint worldwide development expenses on a 50:50 basis, apart from in Japan where Takeda takes care of the development costs. The collaboration gives Seattle Genetics sole commercialization rights in the United States and Canada while Takeda Pharmaceutical Company has commercialization rights in the rest of the globe.

Continue Reading:

http://newschoolmagazine.com/index.php/category/clay-siegall/

http://citrite.org/category/clay-siegall/

When Trying Out WEN By Chaz, Here’s What You Might Expect

Long tangled hair that gets greasy and frizzy can be irritating, and trying to find the perfect shampoo or conditioner formula can be an even bigger challenge. But maybe you’ve heard of Wen hair by Chaz Dean, an all-in-one shampoo and conditioner that’s built to smooth down messy hair and give it a more thick and uniform feeling. It can be an unnerving process when you pick out a new conditioner, and sometimes you need the word of a friend to give you more confidence in trying a new product. A user at Bustle.com, not affiliated WEN by Chaz in any way also decided to take a risk and see if the conditioner met her expectations.

The user, Emily McClure stated that WEN by Chaz gave her a unique feeling when she put it on. Her hair had usually felt a little thin, and greasy to the roots, but whenever she applied this conditioner, it started feeling richer, thicker, and more shiny. She tried it on over the course of seven days to see if the results changed when and where she used it. What she found was that the cleanness and shininess lasted most of the day if she used it in the morning, but it didn’t work nearly as well if applied the night before, and it’s a conditioner that has to be applied daily to get the full effect.

WEN by Chaz is made from natural organic compounds including wild cherry bark, rosemary extract, chamomile, and panthenol. Also all of WEN’s products are made in the USA, so there are no health or safety hazards associated with this product, and its not tested on lab animals. You can buy WEN Hair by Chaz at some local retail stores like Sephora, or you can simply go to Guthy-Renker.com and buy your conditioner from there. You can also get WEN hair through http://www.ebay.com/bhp/wen-hair-care.

Updates? like the official Facebook page.

 

George Soros Shifts His Investments toward the Reviving Biotech Industry

Through his namesake hedge fund ‘Soros Fund Management’, billionaire George Soros has shifted his attention toward investing in the reinvigorating biotechnology sector. A year ago, the hedge fund said that it maintained a put option of 2.1 million shares in the SPDR S&P 500 exchange traded fund involved in tracking the benchmark United States index in its first quarter of 2015. With a put option, the asset management firm was entitled to sell an asset at a specific price.

At the beginning of this year, Soros Fund Management sold its entire shares in the Novavax (NASDAQ: NVAX), iShares Nasdaq Biotechnology Index Fund, (NASDAQ: IBB) and Gilead Sciences (NASDAQ: GILD) in the second quarter of 2016. This is an opportunity for investors particularly those looking for a high-growth investment in the reviving pharmaceutical industry.

According to George Soros, although the biotechnology industry seems to be underperforming citing political blowbacks regarding price controls, the headwind is expected to change upon the election of Hillary Clinton as the next President of the United States.

Novavax is changing toward a pivotal late-stage data readout for its popular F-protein RSV vaccine candidate for the elderly adults. As such, the company at http://latino.foxnews.com/latino/politics/2016/03/10/billionaire-smackdown-george-soros-funds-effort-to-stop-trump-mobilize-latinos/ is expected to generate billions in annual sales. Even if the company stumbles after the failure of the F-protein nanoparticle vaccine, the company hosts a variety of other high-value vaccine candidates that should ease the shock even in the worst case scenario.

Read more:
CNBC.com
US Uncut.news

Gilead Sciences, on the other hand, has staggered after the sales of its popular Hepatitis B drug apparently hit the peak. However, Soros believes that the biotech sector still has a stronger foundation to pursue a merger or acquisition to reinvigorate its top line moving forward.

George Soros is considered the most experienced if not the luckiest hedge fund manager of all time. He is regarded as the ‘man who broke the Bank of England’ after benefiting from the short sales of $10 billion worth of pounds, making a profit of $1 billion during the 1992 Black Wednesday UK Crisis. George Soros is also the man who created over $32 billion in profits since founding Soros Fund Management, making the hedge fund the top profiting funds in the world. As such, it is wise to follow in the footsteps of a man who has been a good source of investment ideas for as long as you can remember.

About Soros Fund Management

Soros Fund Management is an American asset management firm, currently a family office but previously a hedge fund. George Soros established the company in 1969 and as at the end of 2010 was reported as the most profitable hedge funds in the industry. The hedge fund is the primary adviser to the Quantum Group of Funds, a family of funds that deals in international investments.